Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

An Experimental Design for Confirmatory Clinical Trials Testing the Clinical Utility of an Individualization Rule for 2 Treatments.

Created on 06 Nov 2026

Authors

Francisco J Diaz, Byron J Gajewski, Matthew S Mayo

Published in

Medical decision making : an international journal of the Society for Medical Decision Making. Pages 272989X261489606. Nov 06, 2026. Epub Nov 06, 2026.

Abstract

There is a need for efficient and scientifically sound clinical trials that examine the clinical utility of individualized treatment rules (ITRs) that individualize 2 or more medical treatments. These are trials assessing the effectiveness of the medical decision process taking place in the individualization of the treatments, not the effectiveness of the particular treatments involved. We developed a new experimental design for confirming the superiority of an ITR for 2 treatments over decision processes that ignore patient covariates. The design is built on a new published idea, the ITR's individualization potential (IP), which compares the average effect on clinical response (AER) of the ITR with that of treatment without individualization (TWI). The AER of a decision approach compares the expected potential response of a patient treated with the treatment recommended by the approach versus the expected response should the patient be treated with the alternative therapy instead. The IP concept implies a novel way of constructing the control group of our design and testing the ITR's utility. The experimental design provides estimates of the AERs of both the ITR and TWI, which we use to test the individualization potential's statistical significance. In personalized medicine, one of the 2 treatments is often recommended to a subpopulation of lower-frequency patients more difficult to recruit. Thus, as another innovation, our formulation implies convenient sample size calculations that minimize the number of these patients in the total sample size, contrary to traditional methods of powering clinical trials that usually oversample them. Our design usually needs smaller sample sizes than popular designs and has a more appropriate control group. We illustrate calculating sample sizes for a hypothetical ophthalmology clinical trial.

PMID:
42989991
Bibliographic data and abstract were imported from PubMed on 06 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement